Valiant Laboratories Limited
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The c… Read more
Valiant Laboratories Limited (VALIANTLAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: 0.006x
Based on the latest financial reports, Valiant Laboratories Limited (VALIANTLAB) has a cash flow conversion efficiency ratio of 0.006x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹13.13 Million) by net assets (₹2.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Valiant Laboratories Limited - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Valiant Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Valiant Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Valiant Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
D G Khan Cement Company Ltd
KAR:DGKC
|
0.032x |
|
Yoshi Innovation SA
WAR:YOS
|
N/A |
|
Autodrome PLC
CM:AUTON0000
|
N/A |
|
Misitano & Stracuzzi S.p.A.
F:O7E
|
N/A |
|
Phonic Corporation
TWO:3067
|
-0.035x |
|
Character Group
LSE:CCT
|
0.001x |
|
EOI Holding
TW:3717
|
N/A |
|
EFU Life Assurance Ltd
KAR:EFUL
|
N/A |
Annual Cash Flow Conversion Efficiency for Valiant Laboratories Limited (2021–2025)
The table below shows the annual cash flow conversion efficiency of Valiant Laboratories Limited from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹2.34 Billion | ₹13.13 Million | 0.006x | -29.59% |
| 2024-03-31 | ₹2.37 Billion | ₹18.85 Million | 0.008x | -98.57% |
| 2023-03-31 | ₹1.00 Billion | ₹560.51 Million | 0.558x | +1670.70% |
| 2022-03-31 | ₹714.60 Million | ₹22.51 Million | 0.032x | -69.37% |
| 2021-03-31 | ₹885.82 Million | ₹91.09 Million | 0.103x | -- |